Quick answer
Does Zepbound need to be refrigerated? As of September 2026, yes: Zepbound single-dose pens and vials belong in the refrigerator, and the label allows a counted stretch out of it. Section 16.2 Storage and Handling of the Zepbound label (version 40, effective August 28, 2026) reads: "Store ZEPBOUND single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F). If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days." Wegovy (semaglutide) prints a different sentence for its single-dose pen and syringe, and Mounjaro (tirzepatide) prints the same refrigerator and unrefrigerated sentences Zepbound does; both are quoted below, word for word.
One thing to settle before any of those figures: they belong to the FDA-approved product whose label prints them. They do not apply to a compounded vial. A compounded vial carries the beyond-use date assigned by the compounding pharmacy on its own label, and those instructions govern. Compounded medications are not FDA-approved as final products. If your vial came from a compounding pharmacy, read its label first and see the compounded semaglutide storage article.
This article walks through the situations people actually search for: the pen left on the counter, the trip, the warm package. Each is answered only with the label sentence that applies. Where the label is silent, the article says so and gives the one instruction it may add: ask your pharmacist or prescriber.
How long can Zepbound be out of the fridge?
The label does not rule on your particular pen. It gives one time budget, one temperature ceiling, and one word that ties them together. Section 16.2 of the Zepbound label: "If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days. Discard single-dose pen and single-dose vial after a total of 21 days at room temperature."
The word doing the work is "total." Asked how long Zepbound can be unrefrigerated, the label counts that time as a running sum, not a fresh clock each time the pen leaves the refrigerator. The temperature ceiling is the other half: the sentence covers temperatures "not to exceed 30°C (86°F)," and the label prints no figure for a pen that went above that.
So the honest reading is narrow. If you know the pen stayed within the ceiling and you know how much of the total it has used, the label sentence is your answer. If you do not know either, this page cannot fill the gap, and neither can a forum thread: ask your pharmacist or prescriber.
A note on which Zepbound you hold. The sentences above are for the single-dose pen and single-dose vial. The Zepbound KwikPen and the multi-dose vial have their own storage paragraph, which this article does not reproduce; the Zepbound KwikPen article covers that device separately.
How long can Wegovy be out of the fridge?
Wegovy (semaglutide) injection is indicated, in combination with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity, and in adults with overweight in the presence of at least one weight-related comorbid condition, among the indications on its label. Its label, section 16 How Supplied/Storage and Handling (version 19, effective June 18, 2026), says of the single-dose pen and syringe: "Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F). If needed, prior to the pen or syringe cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days."
Read the condition in the middle, "prior to the pen or syringe cap removal," before the figure. The out-of-refrigerator allowance is written for a pen whose cap is still on. The label also states: "Discard the WEGOVY pen or syringe after use."
Two Wegovy products are deliberately left out of this article. The Wegovy FlexTouch single-patient-use pen has its own storage language, and Wegovy tablets have theirs. If you hold either, read your own label and ask your pharmacist or prescriber.
What if I am traveling with Zepbound or Wegovy?
None of the three labels has a travel section. What they have are the sentences already quoted, and those say nothing about coolers, ice packs, or cabin temperatures. This article will not add what the label leaves out.
Two label sentences do apply on the road, because they apply everywhere. Zepbound: "Protect ZEPBOUND from heat and light. Store ZEPBOUND in the original carton to protect from light." Wegovy: "Protect WEGOVY injection from light. WEGOVY injection must be kept in the original carton until time of administration." For anything beyond that, including how to carry the pen and where to keep it once you arrive, ask your pharmacist or prescriber before you leave.
What if the package arrived warm?
This is the one situation where a federal agency has written a direct recommendation. FDA's page on unapproved GLP-1 drugs says: "Injectable GLP-1 drugs require refrigeration as indicated in their package inserts. FDA has received complaints that certain compounded GLP-1 drugs have arrived warm or with inadequate ice packs to keep the drug at recommended storage temperatures." It continues: "The agency recommends patients not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration, as this can affect the drug's quality."
That is the whole of it. A warm package is a question for the pharmacy that shipped it and for your prescriber, before the first injection, not after.
Does a compounded vial follow the Zepbound or Wegovy label?
No. A label belongs to the approved product it was written for. FDA's own compounding page puts the distinction plainly: "This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." Compounded medications are not FDA-approved as final products, so the storage figures on the Zepbound, Mounjaro and Wegovy labels do not transfer to a compounded vial.
What a compounded vial has instead is a beyond-use date assigned by the compounding pharmacy, printed on the pharmacy's own label along with its storage instructions. Those govern. This article prints no beyond-use figure because it cannot know what your pharmacy's label says, and a number copied from somewhere else would be worse than none. Read the label on the vial, and ask the pharmacist who prepared it if anything is unclear.
For the larger questions behind the vial, see is compounded semaglutide FDA approved and is compounded tirzepatide safe.
Does tirzepatide need to be refrigerated? Mounjaro and Zepbound
Mounjaro (tirzepatide) is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus, among the indications on its label. Both Mounjaro and Zepbound contain tirzepatide, and the refrigerator and unrefrigerated sentences for the single-dose pen and vial, quoted below, match word for word. Section 16.2 of the Mounjaro label (version 40, effective August 27, 2026): "Store MOUNJARO single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F). If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days."
The Mounjaro label also says: "Do not freeze MOUNJARO. Do not use MOUNJARO if frozen." As with Zepbound, the Mounjaro KwikPen and multi-dose vial have a separate storage paragraph that this article does not reproduce. For what a GLP-1 receptor agonist is and why these medicines are grouped together, see what is a GLP-1 medication.
Can Zepbound or Wegovy be frozen?
No, and both labels say what to do with a pen that was. Zepbound, section 16.2: "Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen." Wegovy, section 16: "Do not freeze WEGOVY and do not use if it has been frozen." The Wegovy label adds, as a separate line: "Do not store WEGOVY in the freezer or directly adjacent to the refrigerator cooling element."
The Wegovy sentence about the cooling element is worth a second look, because it describes an ordinary refrigerator, not a freezer. The label does not say where that element sits in any particular refrigerator. If you are not sure whether your pen froze, that is a question for your pharmacist or prescriber, not a guess.
Does light matter?
Yes, according to every one of the three labels, and the instruction is the carton. Zepbound: "Protect ZEPBOUND from heat and light. Store ZEPBOUND in the original carton to protect from light." Wegovy: "Protect WEGOVY injection from light. WEGOVY injection must be kept in the original carton until time of administration." Mounjaro: "Protect MOUNJARO from heat and light. Store MOUNJARO in the original carton to protect from light."
Notice that the Zepbound and Mounjaro sentences pair heat with light. The carton is the label's answer to both.
Does Zepbound expire, and how long does tirzepatide last in the fridge?
Yes, Zepbound expires and so does semaglutide. Every carton and pen prints an expiration date, and that printed date governs; it is also the label's only answer to how long tirzepatide or semaglutide lasts in the fridge. This article makes no claim about how long any of these medicines last, because the label makes none beyond the date it prints and the storage sentences quoted above. The out-of-refrigerator allowance is not an extension of the expiration date; it is a separate limit that sits alongside it.
For a compounded vial, the beyond-use date on the pharmacy label plays that role. If you are not sure which date on your packaging is which, how to read a prescription label walks through the parts of the label.
Who answers what the label does not?
Your pharmacist or your prescriber. That is the only instruction this article adds to the label text, and it is the right one for every gap above. Tell them what you know, and let them decide.
When the pen is in your hand and the question is where to inject rather than how to store, the Zepbound injection sites article covers what the Instructions for Use say.
This article is for informational purposes only and does not constitute medical advice. Medication is prescribed only if a licensed physician determines it is appropriate. Storage sentences are quoted verbatim from the FDA-approved labels named above; read the label and the Instructions for Use that came with your own medicine.
Frequently Asked Questions
Does Zepbound need to be refrigerated?
Yes. Section 16.2 of the Zepbound label says: "Store ZEPBOUND single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F)." The label then allows a limited, counted period out of the refrigerator, quoted in the article.
Does time out of the fridge reset each time the Zepbound pen goes back in?
The Zepbound label, section 16.2, says: "If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days. Discard single-dose pen and single-dose vial after a total of 21 days at room temperature." The word "total" is the label's own: it is a running count, not a fresh clock each time. If you are unsure how long your pen was out or how warm it got, ask your pharmacist or prescriber.
Does tirzepatide need to be refrigerated?
Both FDA-approved tirzepatide products carry refrigerator storage on their labels. Zepbound and Mounjaro use matching wording for the single-dose pen and vial: "Store MOUNJARO single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F)." A compounded tirzepatide vial is not covered by either label; it follows the beyond-use date on the compounding pharmacy's own label.
Does the Wegovy out-of-refrigerator allowance apply after the cap is removed?
The label sentence is written for a pen whose cap is still on: "If needed, prior to the pen or syringe cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days." The label also says: "Discard the WEGOVY pen or syringe after use." For a pen whose cap was removed and not used, this article adds nothing; ask your pharmacist or prescriber.
What if my Zepbound or Wegovy pen was frozen?
Both labels are direct. Zepbound: "Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen." Wegovy: "Do not freeze WEGOVY and do not use if it has been frozen." The Wegovy label also says, on a separate line: "Do not store WEGOVY in the freezer or directly adjacent to the refrigerator cooling element." If you are not sure whether your pen froze, ask your pharmacist or prescriber.
Does semaglutide expire?
Yes. Every Wegovy carton and pen prints an expiration date, and that printed date governs; nothing in the label's storage sentences extends it. A compounded semaglutide vial does not carry the Wegovy label's date at all; it carries a beyond-use date assigned by the compounding pharmacy, and that date and those instructions govern.
Does the out-of-refrigerator allowance apply to the Zepbound KwikPen?
No figure in this article applies to it. The sentences quoted here are for the Zepbound single-dose pen and single-dose vial. The Zepbound KwikPen and the multi-dose vial have their own storage paragraph on the label, which this article does not reproduce; the Zepbound KwikPen article covers that device, and your pharmacist or prescriber can read your own label with you.
My package arrived warm. Can I still use it?
FDA's page on unapproved GLP-1 drugs says: "The agency recommends patients not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration, as this can affect the drug's quality." Contact the pharmacy that shipped it and your prescriber before using it.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.Zepbound (tirzepatide) prescribing information, section 16.2 Storage and Handling, label version 40, effective 08/28/2026, set id 487cd7e7-434c-4925-99fa-aa80b1cc776b · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 2.Zepbound (tirzepatide) prescribing information, section 16.2 Storage and Handling, freezing and light sentences, label version 40, effective 08/28/2026 · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 3.Zepbound (tirzepatide) prescribing information, section 1 Indications and Usage, label version 40, effective 08/28/2026 · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 4.Wegovy (semaglutide) prescribing information, section 16 How Supplied/Storage and Handling, single-dose pen and single-dose syringe storage, label version 19, effective 06/18/2026, set id ee06186f-2aa3-4990-a760-757579d8f77b · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 5.Wegovy (semaglutide) prescribing information, section 16, freezing and light sentences, label version 19, effective 06/18/2026 · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 6.Wegovy (semaglutide) prescribing information, section 1 Indications and Usage, label version 19, effective 06/18/2026 · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 7.Mounjaro (tirzepatide) prescribing information, section 16.2 Storage and Handling, label version 40, effective 08/27/2026, set id d2d7da5d-ad07-4228-955f-cf7e355c8cc0 · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 8.Mounjaro (tirzepatide) prescribing information, section 1 Indications and Usage, label version 40, effective 08/27/2026 · DailyMed, U.S. National Library of Medicine (label text read through the openFDA drug label API) · accessed
- 9.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (page dated 09/01/2026, Wayback capture 2026-09-14) · U.S. Food and Drug Administration · accessed
- 10.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, storage during shipping (page dated 09/01/2026, Wayback capture 2026-09-14) · U.S. Food and Drug Administration · accessed
- 11.Compounding and the FDA: Questions and Answers (Wayback capture 2026-09-18) · U.S. Food and Drug Administration · accessed
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them
